KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $862,359 | -63.8% | 5,100 | -53.6% | 0.00% | -71.4% |
| Q2 2023 | $2,385,350 | -34.2% | 11,000 | -44.9% | 0.01% | -12.5% |
| Q1 2023 | $3,625,898 | -44.7% | 19,962 | -40.2% | 0.01% | -57.9% |
| Q4 2022 | $6,557,402 | -11.8% | 33,371 | +0.9% | 0.02% | -17.4% |
| Q3 2022 | $7,436,000 | +7.4% | 33,058 | -39.6% | 0.02% | 0.0% |
| Q2 2022 | $6,924,000 | +212.7% | 54,723 | +213.4% | 0.02% | +228.6% |
| Q1 2022 | $2,214,000 | +106.0% | 17,459 | +112.9% | 0.01% | +133.3% |
| Q4 2021 | $1,075,000 | +326.6% | 8,200 | +290.5% | 0.00% | +200.0% |
| Q1 2021 | $252,000 | -82.3% | 2,100 | -85.0% | 0.00% | -83.3% |
| Q4 2020 | $1,423,000 | +611.5% | 14,000 | +677.8% | 0.01% | +500.0% |
| Q2 2020 | $200,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |